⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
prnewswire.com
MLTX
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Securities Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake Immunotherapeutics (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate - Hagens Berman
accessnewswire.com
MLTX
Securities Fraud Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Reminds Investors of December 15, 2025
accessnewswire.com
MLTX